Oscillating positive expiratory pressure (OPEP) breathing exerciser trainers in airway clearance therapy for patients with respiratory diseases
- Authors: Babak S.L.1, Gorbunova M.V1, Malyavin A.G1
-
Affiliations:
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry
- Issue: Vol 28, No 10 (2021)
- Pages: 52-58
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313253
- DOI: https://doi.org/10.18565/pharmateca.2021.10.52-58
- ID: 313253
Cite item
Open Access
Access granted
Abstract
Oscillating positive expiratory pressure (OPEP) breathing exerciser trainers are portable medical devices for non-drug therapy that enhance mobilization and improve drainage of sputum and mucus from the airways of hypersecreting patients. In most respiratory diseases, especially those accompanied by hypersecretion, drainage and secret expectoration significantly improve pulmonary mechanics and gas exchange, reduce the severity of dyspnea, reduce the number of repeated exacerbations and hospitalizations, and improve the quality of life. We analyzed the available OPEP devices for their effectiveness, cost-effectiveness and benefit for patients based on available clinical studies and formulated proposals for the inclusion of some OPEP devices in airway clearance therapy regimens for patients with respiratory diseases.
Full Text
About the authors
Sergey L. Babak
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Email: sergbabak@mail.ru
Dr. Sci. (Med.), Professor at the Department of Phthisiology and Pulmonology, Faculty of Medicine Moscow, Russia
M. V Gorbunova
A.I. Yevdokimov Moscow State University of Medicine and DentistryMoscow, Russia
A. G Malyavin
A.I. Yevdokimov Moscow State University of Medicine and DentistryMoscow, Russia
References
- Россия в цифрах. 2020: Крат. стат. сб. Росстат. M., 2020. с. 165. URL: https://gks.ru/folder/210/document/13218 (дата доступа/Access date: 29.08.2021).
- Ramos F.L., Krahnke J.S., Kim К. Clinical issues of mucus accumulation in COPD. int J Chron Obstruct Pulmon Dis. 2014;9:139-50. doi: 10.2147/COPD.S38938.
- Shen Y., Huang S., Kang J., et al. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition). int J Chron Obstruct Pulmon Dis. 2018;13:399-407. doi: 10.2147/COPD. S144312.
- Global strategy for the diagnosis, management and prevention of COPD (2020 Report). URL: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.1wms.pdf.
- Andrews J., Sathe N.A., Krishnaswami S., McPheeters M.L. Nonpharmacologic airway clearance techniques in hospitalized patients: a systematic review. Respir Care. 2013;58(12):2160-86. Doi: 10.4187/ respcare.02704.
- Myers T.R. Positive expiratory pressure and oscillatory positive expiratory pressure therapies. Respir Care. 2007;52(10):1308-26; discussion 1327.
- Wolkove N., Kamel H., Rotaple M., Baltzan M.A. Jr. Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD. Chest. 2002;121(3):702-7. doi: 10.1378/chest.121.3.702.
- Burudpakdee C., Seetasith A., Dunne P., et al. A Real-World Study of 30-Day Exacerbation Outcomes in Chronic Obstructive Pulmonary Disease (COPD) Patients Managed with Aerobika OPEP Pulm Ther. 2017;3:163-71. Doi: 10.1007/ s41030-017-0027-5.
- Khoudigian-Sinani S., Kowal S., Suggett J.A., Coppolo D.P. Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations. int J Chron Obstruct Pulmon Dis. 2017;12:30 65- 73. doi: 10.2147/COPD.S143334.
- Svenningsen S., Paulin G.A., Sheikh K., et al. Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease. COPD. 2016;13(1):66-74. doi: 10.3109/15412555.2015.1043523.
- Tse J., Wada K., Wang Y., et al. impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika® and Acapella® Devices. int J Chron Obstruct Pulmon Dis. 2020;15:2527-38. doi: 10.2147/COPD. S256866.
- Morrison L., Milroy S. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev. 2020;4(4):CD006842. doi: 10.1002/14651858.CD006842.pub5.
- West K., Wallen M., Follett J. Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation. Physiother Theory Pract. 2010;26(3):143-49.
- Suggett J.A., Meyer A., Costella S., et al. Assessment of oscillating positive expiratory pressure (OPEP) devices by means of adult expiratory waveforms: a laboratory study. Am J Resp Crit Care Med. 2014;189: 036. doi: 10.1164/ajrccm-conference. 2014.189
- Volsko T.A., DiFiore J., Chatburn R.L. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care. 2003;48(2):124-30.
- Van Fleet H., Dunn D.K., McNinch N.L., Volsko T.A. Evaluation of Functional Characteristics of 4 Oscillatory Positive Pressure Devices in a Simulated Cystic Fibrosis Model. Respir Care. 2017;62(4):451-58. Doi: 10.4187/ respcare.04570.
- Poncin W., Reychler G., Liistro M., Liistro G. Comparison of 6 Oscillatory Positive Expiratory Pressure Devices During Active Expiratory Flow. Respir Care. 2020;65(4):492-99. Doi: 10.4187/ respcare.07271.
- Aerobika® Oscillating positive expiratory pressure therapy system. Trudell Medical international. instructions. Available from: https://www.trudellmed.com/products/aerobika-opepde-vice - data 3 September 2021.
- Flutter Mucus Clearance Device. instructions. Available from: https://media.allergan.com/actavis/actavis/media/allergan-pdf-documents/ product-prescribing/Flutter.pdf - data 3 September 2021
- Измерение давления выдоха и частоты вибрации дыхательных тренажёров Respiro O2IN и Acapella. URL: https://www.o2in.ru/test (дата доступа/Access date: 03.10.2021).
- Bourbeau J, McIvor A.R., Devlin H.M., Kaplan A. Oscillating positive expiratory pressure (OPEP) device therapy in Canadian respiratory disease management: Review, care gaps and suggestion for use. Can J Resp Crit Care Sleep Medicine. 2019:(3):233-40. doi: 10.1080/24745332.2 018.1558426
Supplementary files
